Trios Pharmaceuticals Private Limited

Produces and distributes pharmaceutical products for medical institutions and research facilities.

2005 | Delhi (India) | Active
Last Updated:

Trios Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.60 M
  • Company Age 19 Year, 3 Months
  • Last Filing with ROC 31 Mar 2019
  • Open Charges ₹ 2.00 M
  • Revenue Growth -18.84%
  • Profit Growth -4.24%
  • Ebitda -26.48%
  • Net Worth -6.13%
  • Total Assets 10.77%

About Trios Pharmaceuticals

Trios Pharmaceuticals Private Limited (TPPL) is a Private Limited Indian Non-Government Company incorporated in India on 31 October 2005 and has a history of 19 years and three months. Its registered office is in Delhi, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.60 M.

The company currently has active open charges totaling ₹2.00 M.

Amit Bhatia and Sunil Kumar serve as directors at the Company.

Company Details

  • Location

    Delhi, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24231DL2005PTC142226

  • Company No.

    142226

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    31 Oct 2005

  • Date of AGM

    30 Sep 2019

  • Date of Balance Sheet

    31 Mar 2019

  • Listing Status

    Unlisted

  • ROC Code

    Roc Delhi

Industry

Pharma

Who are the key members and board of directors at Trios Pharmaceuticals?

Board Members (2)

NameDesignationAppointment DateStatus
Amit Bhatia Country flag representing In Director 31-Oct-2005Current
Sunil Kumar Country flag representing In Director 01-Sep-2015Current

Financial Performance of Trios Pharmaceuticals.

Trios Pharmaceuticals Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 18.84% decrease. The company also saw a slight decrease in profitability, with a 4.24% decrease in profit. The company's net worth dipped by a decrease of 6.13%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-18.84%
Revenue from Operations
-18.84%
Total Assets
10.77%
Profit or Loss
-4.24%
Net Worth
-6.13%
EBITDA
-26.48%

What is the Ownership and Shareholding Structure of Trios Pharmaceuticals?

In 2017, Trios Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹2.00 M

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Icici Bank : 0.20 Cr

Latest Charge Details

DateLenderAmountStatus
17 Dec 2015Icici Bank₹2.00 MOpen

How Many Employees Work at Trios Pharmaceuticals?

Unlock and access historical data on people associated with Trios Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Trios Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Trios Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Trios Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Trios Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records.

    30 Sep 2019

  • Balance Sheet

    Trios Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Delhi.

    31 Mar 2019

  • Charges

    A charge with Icici Bank amounted to Rs. 2.00 M with Charge ID 10617447 was registered on 17 Dec 2015.

    17 Dec 2015

  • Director Appointment

    Sunil Kumar was appointed as a Director was appointed as a Director on 01 Sep 2015 & has been associated with this company since 9 years 5 months .

    01 Sep 2015

  • Director Appointment

    Amit Bhatia was appointed as a Director was appointed as a Director on 31 Oct 2005 & has been associated with this company since 19 years 3 months .

    31 Oct 2005

  • Company Incorporation

    Trios Pharmaceuticals Private Limited was registered on 31 Oct 2005 with Roc Delhi & aged 19 years 3 months as per MCA records.

    31 Oct 2005

Frequently asked questions

  • What is the Incorporation or founding date of Trios Pharmaceuticals Private Limited?

    Trios Pharmaceuticals Private Limited was incorporated on 31 Oct 2005.

  • What is authorized share capital and paid-up capital of Trios Pharmaceuticals Private Limited?

    The authorized share capital of Trios Pharmaceuticals Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.60 M.

  • Who are the current board members & directors of Trios Pharmaceuticals Private Limited?

    Currently 2 directors are associated with Trios Pharmaceuticals Private Limited.

    • Amit Bhatia
    • Sunil Kumar

  • What is the registered address of Trios Pharmaceuticals Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Trios Pharmaceuticals Private Limited is H No 92-Aparteek Market Munirka India, New Delhi, 110067.

  • What is the corporate identification number (CIN) and company number of Trios Pharmaceuticals Private Limited?

    The corporate identification number (CIN) of Trios Pharmaceuticals Private Limited is U24231DL2005PTC142226 and the company number is 142226 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Trios Pharmaceuticals Private Limited?

    According to the financial reports for the fiscal year 2019, the revenue trend for Trios Pharmaceuticals Private Limited has fallen by -18.84%.

  • What change has been observed in the net worth of Trios Pharmaceuticals Private Limited, and by what percentage?

    The financial reports for the fiscal year 2019 indicates that The net worth of Trios Pharmaceuticals Private Limited has experienced an downturn of -6.13%.

  • What are the total open charges for Trios Pharmaceuticals Private Limited?

    As per the financial statements for fiscal Year 2019, The total open charges for Trios Pharmaceuticals Private Limited amount to ₹ 2.00 M.

  • When was the last Balance Sheet of Trios Pharmaceuticals Private Limited filed with the ROC?

    The most recent Balance Sheet for Trios Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2019.

People also Viewed

Similar Companies Based on Drug Formulation & Development